Bone Health Risks Associated with Finasteride and Dutasteride Long-Term Use

April 2021 in “ The World Journal of Men's Health ”

Maria Maddalena Sirufo, Lia Ginaldi, Massimo De Martinis

We don't know much about this study yet.

We're maintaining the world's largest resposity of hair loss research. You can help out the community by sending a PDF of this study here . Not sure how to get a study's PDF? You can email the authors of the study.

View this study on wjmh.org →

Discuss this study in the Community →

Cited in this study

3 / 3 results

research Health Risks Associated with Long-Term Finasteride and Dutasteride Use: It's Time to Sound the Alarm

17 citations , July 2020 in “The World Journal of Men's Health”

research A Population-Based Study of the Risk of Osteoporosis and Fracture with Dutasteride and Finasteride

4 citations , May 2018 in “BMC Musculoskeletal Disorders”

Dutasteride and finasteride have similar risk for osteoporosis and fractures in older men.

research A Population-Based Nested Case-Control Study: The Use of 5-Alpha-Reductase Inhibitors and the Increased Risk of Osteoporosis Diagnosis in Patients with Benign Prostate Hyperplasia

22 citations , November 2014 in “Clinical endocrinology”

Taking finasteride for benign prostate hyperplasia may increase the risk of osteoporosis, especially at higher doses.

2 / 2 results

research Finasteride for Hirsutism: A Dose Finding Study

8 citations , January 1998 in “PubMed”

research Outcome of Long-Term Treatment with the 5α-Reductase Inhibitor Finasteride in Idiopathic Hirsutism: Clinical and Hormonal Effects During a 1-Year Course of Therapy and 1-Year Follow-Up

75 citations , November 1996 in “Fertility and Sterility”

Finasteride effectively reduces hair growth in women with idiopathic hirsutism, but requires careful contraception during treatment.